National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 16218-16219 [2022-05967]
Download as PDF
<![CDATA[
16218
ACTION:
Federal Register / Vol. 87, No. 55 / Tuesday, March 22, 2022 / Notices
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice entitled ‘‘Verification Systems
Under the Drug Supply Chain Security
Act for Certain Prescription Drugs; Draft
Guidance for Industry’’ that appeared in
the Federal Register of March 10, 2022.
The document omitted the date by
which comments on the draft guidance
should be submitted to FDA. This error
is corrected in this document for clarity.
FOR FURTHER INFORMATION CONTACT:
Sarah Venti, Office of Compliance,
Center for Drug Evaluation and
Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993–0002,
301–796–3130, drugtrackandtrace@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of March 10, 2022 (87
FR 13738), appearing on page 13738, in
FR Doc. 2022–05018, in the second
column, the DATES section is corrected
to read as follows:
DATES: The announcement of the
guidance is published in the Federal
Register on March 10, 2022. Although
you can comment on any guidance at
any time (see 21 CFR 10.115(g)(5)), to
ensure that the Agency considers your
comment on this draft guidance before
it begins work on the final version of the
guidance, submit either electronic or
written comments on the draft guidance
by May 9, 2022.
SUMMARY:
Dated: March 17, 2022.
Andi Lipstein Fristedt,
Deputy Commissioner for Policy, Legislation,
and International Affairs, U.S. Food and Drug
Administration.
[FR Doc. 2022–06006 Filed 3–21–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute of Diabetes and
Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Diabetes and Digestive and Kidney
Diseases Special Emphasis Panel, March
23, 2022, 09:00 a.m. to March 24, 2022,
04:00 p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD, 20892 which was
published in the Federal Register on
February 25, 2022, 308582.
Dr. Kozel wants to change the date for
his meeting. The meeting is closed to
the public.
VerDate Sep<11>2014
18:24 Mar 21, 2022
Jkt 256001
Dated: March 16, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2022–05966 Filed 3–21–22; 8:45 am]
Center for Scientific Review; Amended
Notice of Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Acquired Immunodeficiency
Syndrome Research Study Section; Acquired
Immunodeficiency Syndrome Research
Study Section (AIDS).
Date: April 20, 2022.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F40A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Dimitrios Nikolaos
Vatakis, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, MSC–
9823, Bethesda, MD 20892, (301) 761–7176,
dimitrios.vatakis@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 16, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05968 Filed 3–21–22; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
National Institutes of Health
Notice is hereby given of a change in
the meeting of the Sleep Disorders
Research Advisory Board, April 7, 2022,
12:00 p.m. to 5:00 p.m., Virtual Meeting,
which was published in the Federal
Register on March 09, 2022, V 87 Vol.
46, Page 13302, FR Doc No. 2022–
04982.
Meeting is being amended to change
the telephone call in number to 1–669–
254–5252 (Meeting ID: 161 532 8417
Passcode: 330488). The meeting is open
to the public.
Dated: March 16, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05969 Filed 3–21–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trials and
Comparative Effectiveness Studies in
Neurology.
Date: March 28–29, 2022.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
E:\FR\FM\22MRN1.SGM
22MRN1
16219
Federal Register / Vol. 87, No. 55 / Tuesday, March 22, 2022 / Notices
NINDS/NIH, NSC, 6001 Executive Boulevard,
Suite 3208, MSC 9529, Bethesda, MD 20892,
301–435–6033, rajarams@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: March 16, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05967 Filed 3–21–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361.
Proposed Project: Pretesting of
Substance Abuse Prevention and
Treatment and Mental Health Services
Communications Messages—(OMB No.
0930–0196)—Reinstatement
As the federal agency responsible for
developing and disseminating
authoritative knowledge about
substance abuse prevention, addiction
BILLING CODE 4140–01–P
Number of
respondents
Activity
Individual In-depth Interviews:
General Public ..................................
Service Providers ..............................
Focus Group Interviews:
General Public ..................................
Service Providers ..............................
Telephone Interviews:
General Public ..................................
Service Providers ..............................
Self-Administered Questionnaires:
General Public ..................................
Service Providers ..............................
Gatekeeper Reviews:
General Public ..................................
Service Providers ..............................
Total ...........................................
Responses/
respondent
Hours per
response
treatment, and mental health services
and for mobilizing consumer support
and increasing public understanding to
overcome the stigma attached to
addiction and mental illness, SAMHSA
is responsible for development and
dissemination of a wide range of
education and information materials for
both the general public and the
professional communities. This
submission is for generic approval and
will provide for formative and
qualitative evaluation activities to; (1)
assess audience knowledge, attitudes,
behavior and other characteristics for
the planning and development of
messages, communication strategies and
public information programs; and (2)
test these messages, strategies and
program components in developmental
form to assess audience comprehension,
reactions, and perceptions. Information
obtained from testing can then be used
to improve materials and strategies
while revisions are still affordable and
possible. The annual burden associated
with these activities is summarized
below.
Hourly wage
rate
($) 1
Total hours
Total Hour
cost
($)
400
200
1
1
.75
.75
300
150
$25.00
35.00
7,500
5,250
3,000
1,500
1
1
1.5
1.5
4,500
2,250
25.00
35.00
112,500
78,750
335
165
1
1
.08
.08
27
13
25.00
35.00
675
455
2,680
1,320
1
1
.25
.25
670
330
25.00
35.00
16,750
11,550
1,200
900
1
1
.50
.50
600
450
25.00
35.00
15,000
15,750
11,700
........................
........................
9,290
........................
264,180
1
lotter on DSK11XQN23PROD with NOTICES1
The hourly wage of $25.00 for the general public was calculated based on weighted data from the 2019 NSDUH respondents’ personal annual income. The $35 hourly wage rate for providers is an average across counselors and other service provider staff.
Written comments and
recommendations concerning the
proposed information collection should
be sent by April 21, 2022 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
VerDate Sep<11>2014
18:24 Mar 21, 2022
Jkt 256001
for Public Comments’’ or by using the
search function.
DEPARTMENT OF HOMELAND
SECURITY
Carlos Graham,
Reports Clearance Officer.
U.S. Customs and Border Protection
[FR Doc. 2022–06051 Filed 3–21–22; 8:45 am]
[1651–0010]
BILLING CODE 4162–20–P
PO 00000
Certificate of Registration (CBP Forms
4455 and 4457)
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 60-Day notice and request for
comments; extension of an existing
collection of information.
AGENCY:
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 87, Number 55 (Tuesday, March 22, 2022)]
[Notices]
[Pages 16218-16219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05967]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Clinical Trials and Comparative
Effectiveness Studies in Neurology.
Date: March 28-29, 2022.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Shanta Rajaram, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities,
[[Page 16219]]
NINDS/NIH, NSC, 6001 Executive Boulevard, Suite 3208, MSC 9529,
Bethesda, MD 20892, 301-435-6033, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: March 16, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-05967 Filed 3-21-22; 8:45 am]
BILLING CODE 4140-01-P
